Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ALVO is expected to report earnings to fall 114.89% to 2 cents per share on May 07
Q1'25
Est.
$0.03
Q4'24
Missed
by $0.19
Q3'24
Beat
by $0.03
Q2'24
Missed
by $0.59
Q1'24
Missed
by $0.81
The last earnings report on March 26 showed earnings per share of -18 cents, missing the estimate of 0 cents. With 180.80K shares outstanding, the current market capitalization sits at 3.48B.